Search research articles
Contact Us
Filters
Showing results (51-60 of 64) with videos related to
Page
of 7
Sort By:
Diagnostic Microbiology and Infectious Disease
|
November 1, 2001
Multicenter prospective surveillance of oral Candida dubliniensis among adult Brazilian human immunodeficiency virus-positive and AIDS patients
E P Milan, P de Laet Sant' Ana, A S de Azevedo Melo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
June 14, 2015
Initial serum (1,3)-β-D-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil
D R Giacobbe, P Esteves, P Bruzzi, et al.
Journal of Clinical Microbiology
|
April 20, 2007
Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing
M A Pfaller, D J Diekema, D L Gibbs, et al.
Nature Biotechnology
|
February 3, 1998
Production of the antitumor drug epirubicin (4'-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius
K Madduri, J Kennedy, G Rivola, et al.
Journal of Clinical Microbiology
|
May 29, 2001
Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela
B M Calvo, A L Colombo, O Fischman, et al.
Journal of Bacteriology
|
December 29, 1998
Doxorubicin overproduction in Streptomyces peucetius: cloning and characterization of the dnrU ketoreductase and dnrV genes and the doxA cytochrome P-450 hydroxylase gene
N Lomovskaya, S L Otten, Y Doi-Katayama, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
July 20, 2002
Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole
J S R Oliveira, F R Kerbauy, A L Colombo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
May 12, 2009
Clinical and microbiological assessment of patients with a long-term diagnosis of human immunodeficiency virus infection and Candida oral colonization
A C D Delgado, R de Jesus Pedro, F H Aoki, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 20, 2016
Predictors of choice of initial antifungal treatment in intraabdominal candidiasis
L Lagunes, B Borgatta, M T Martín-Gomez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 17, 2019
Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres
E C Francisco, J N de Almeida Junior, F de Queiroz Telles, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 64) with videos related to
Sort By:
Page
of 7
Diagnostic Microbiology and Infectious Disease
|
November 1, 2001
Multicenter prospective surveillance of oral Candida dubliniensis among adult Brazilian human immunodeficiency virus-positive and AIDS patients
E P Milan, P de Laet Sant' Ana, A S de Azevedo Melo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
June 14, 2015
Initial serum (1,3)-β-D-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil
D R Giacobbe, P Esteves, P Bruzzi, et al.
Journal of Clinical Microbiology
|
April 20, 2007
Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing
M A Pfaller, D J Diekema, D L Gibbs, et al.
Nature Biotechnology
|
February 3, 1998
Production of the antitumor drug epirubicin (4'-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius
K Madduri, J Kennedy, G Rivola, et al.
Journal of Clinical Microbiology
|
May 29, 2001
Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela
B M Calvo, A L Colombo, O Fischman, et al.
Journal of Bacteriology
|
December 29, 1998
Doxorubicin overproduction in Streptomyces peucetius: cloning and characterization of the dnrU ketoreductase and dnrV genes and the doxA cytochrome P-450 hydroxylase gene
N Lomovskaya, S L Otten, Y Doi-Katayama, et al.
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas
|
July 20, 2002
Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole
J S R Oliveira, F R Kerbauy, A L Colombo, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
May 12, 2009
Clinical and microbiological assessment of patients with a long-term diagnosis of human immunodeficiency virus infection and Candida oral colonization
A C D Delgado, R de Jesus Pedro, F H Aoki, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 20, 2016
Predictors of choice of initial antifungal treatment in intraabdominal candidiasis
L Lagunes, B Borgatta, M T Martín-Gomez, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
April 17, 2019
Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres
E C Francisco, J N de Almeida Junior, F de Queiroz Telles, et al.
Page
of 7